Hyderabad, May 11 -- Abbott, a global healthcare leader, today announced the launch of the TriClip transcatheter edge-to-edge repair (TEER) system in India for the treatment of tricuspid regurgitation (TR), commonly known as a leaky tricuspid valve.
The minimally invasive device is designed to repair the tricuspid valve without the need for open-heart surgery and is delivered through a vein in the leg using catheter-based technology, the company said in a release..
According to the company, the TriClip system works by clipping together portions of the valve leaflets to improve blood flow and reduce leakage.
The technology is based on Abbott's MitraClip platform used for treating leaky mitral valves but has been specifically engineered fo...